Nuvation Bio Inc (NUVB)
Official siteHEALTHCARE • BIOTECHNOLOGY • NYSE
Market Cap: $1.41B
Last updated: Nov 17, 2026 at 4:43 PM ET
Nuvation Bio Inc (NUVB) Stock Chart
Nuvation Bio (NUVB) has a latest price of $3.91 on Nov 17, 2026, 59.9% below its 52-week high of $9.75. Its price fell 19.5% over the past 12 months. The month-end price fell 48.1% over the 5 years through Oct 2026, a compound annual decline of 12.3%.
Price Chart
From Aug 2020 to Oct 2026, its highest month-end close was $14.22 in May 2021 and its lowest $0.96 in Oct 2023, adjusted for splits.
Month-end closes, adjusted for splits. Dividends are not included.
Chart NUVB with Advanced Charting
Daily candlesticks, valuation multiples, side-by-side comparisons and drawings for NUVB.
Free with a GNG account. No credit card.
Price Performance
Over the past 3 months the price fell 46.1%, and over 6 months it fell 7.8%. The month-end price rose 394.0% over the 3 years through Oct 2026, a compound annual rate of 70.3%.
| Period | Change |
|---|---|
| 1 month | -12.7% |
| 3 months | -46.1% |
| 6 months | -7.8% |
| 12 months | -19.5% |
| 12 months, with dividends | -19.5% |
| Period | Change | Per year |
|---|---|---|
| 3 years | +394.0% | +70.3% |
| 5 years | -48.1% | -12.3% |
Price by Year
Its best calendar year was 2025, when the price rose 236.8%, and its weakest was 2022, when it fell 77.4%.
| Year | Close | Change |
|---|---|---|
| 2026 through Oct 2026 | $4.76 | -46.9% |
| 2025 | $8.96 | +236.8% |
| 2024 | $2.66 | +76.2% |
| 2023 | $1.51 | -21.4% |
| 2022 | $1.92 | -77.4% |
| 2021 | $8.50 | -27.4% |
Trading Range
The price is 22.1% below its 50-day average of $5.02 and 26.4% below its 200-day average of $5.31.
| Measure | Value | Price vs |
|---|---|---|
| Latest price (Nov 17, 2026) | $3.91 | |
| 52-week high | $9.75 | -59.9% |
| 52-week low | $3.82 | +2.4% |
| 50-day average | $5.02 | -22.1% |
| 200-day average | $5.31 | -26.4% |
Price Risk
Over 3 years, its largest fall from a peak was 59.8%.
| Measure | Value |
|---|---|
| 1-year beta | 1.74 |
| Largest fall, 1 year | -59.7% |
| Largest fall, 3 years | -59.8% |
Advanced Charting Features
Advanced Charting is free with a GNG account, and signed-in members get it in place of the price chart above.
- Valuation multiples. Daily P/E, price to sales, cash flow and book value, PEG and PEGY, drawn behind the price wherever the company's data supports them.
- Price charts and drawings. Candlestick, OHLC, line and area charts with volume and earnings, dividend and split markers, plus trend lines, levels and notes kept in your account.
- Side-by-side compare. Two stocks next to each other on one metric and time span, each chart with its own price scale.
- Projections and saved views. Pick a start and an end point to see the price return, dividends and total return between them, and save views to open later.
Frequently Asked Questions About NUVB
What is NUVB's 1-year price change?
Nuvation Bio's price fell 19.5% over the past 12 months. With dividends included, the 12-month total return was -19.5%.
What is NUVB's 5-year price change?
Nuvation Bio's month-end price fell 48.1% over the 5 years through Oct 2026, a compound annual decline of 12.3%. These figures leave out dividends.
What is NUVB's 52-week high and low?
Nuvation Bio's 52-week high is $9.75 and its 52-week low is $3.82. Its latest price of $3.91 on Nov 17, 2026 is 59.9% below the high.
What is NUVB's beta?
Nuvation Bio's 1-year beta against the S&P 500 is 1.74, so its price has moved more than the market over the past year. Its largest fall from a peak over the past year was 59.7%.
Is the NUVB chart free?
Yes. Advanced Charting for NUVB is free with a GNG account, and no credit card is needed. It adds daily candlestick and line charts with volume, valuation multiples, side-by-side comparisons, drawings and saved views.
NUVB pages: Overview, Charting, Earnings, Forecast, Financials, Statistics, Competitors